Sign in
8-K

Current Report

Aclaris Therapeutics, Inc. Filed Acc 0001104659-26-119231

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading tm2628355d1_8k.htm…